PA Consulting and PulPac’s Blister Pack Collective welcome Sanofi Consumer Healthcare on its journey to reduce single use-plastic packaging
PA Consulting (PA), the company bringing ingenuity to life, and PulPac, the Swedish packaging solutions company behind Dry Molded Fiber (DMF), are pleased to announce that Sanofi’s Consumer Healthcare (CHC) business has joined the Blister Pack Collective. Sanofi CHC first announced that it joined PA and PulPac’s Bottle Collective back in April 2023.
The Blister Pack Collective brings together pharma, consumer health, and FMCG businesses to accelerate progress towards a world with more sustainable blister packaging, free from problem plastics like PVC. PA and PulPac have seeded the collective and developed the underlying technology needed to bring a functioning DMF tablet blister pack to life. The adoption of Dry Molded Fiber tablet packs provides an opportunity to cut back on the 100,000+ tonnes of plastic medicine packaging used every year.
As a founding member of both the Blister Pack and Bottle Collectives, Sanofi CHC is investing in the development of Dry Molded Fiber packaging to support their mission to build a healthier, more resilient world. Dry Molded Fiber blister packs and bottles are designed to be recycled in the same way as paper packaging and will reduce or eliminate Sanofi CHC’s single-use plastic packaging, significantly improving the environmental profile of Sanofi CHC’s future product portfolio.
Dry Molded Fiber technology minimises CO₂ emissions – leaving up to an 80% lower CO₂ footprint than plastic and wet molded fiber – and requires minimal water usage. It enables the production of versatile tablet packs that are comparable to PVC packs in terms of design and tablet count.
Tony Perrotta, PulPac Partnership Lead at PA Consulting, said: “We are delighted to join forces with Sanofi CHC on the Blister Pack Collective. Sanofi CHC is already leading the way with DMF integrations in their Bottle Collective work, and this additional partnership will lead to a better environmental footprint and reduced plastics in future healthcare packaging.”
Sanna Fager, Chief Commercial Officer at PulPac, said: “We are very happy that a renowned brand like Sanofi CHC joins the collective and validates the innovative power of Dry Molded Fiber. From the very beginning, we set out to replace single-use plastics at a global scale by building an ecosystem of changemakers around our technology. We are excited to see that vision come to life and be embraced by the industry. When brands join forces, change becomes not only possible but also inevitable.”
France Depaix, Global Head of Design, Product Sustainability, and Packaging Innovation at Sanofi Consumer Healthcare, said: “We are proud to be a part of the Blister Pack Collective, as we take significant steps to reduce our environmental footprint and contribute to a healthier planet. By fostering collaboration and adopting innovative solutions, we aspire to set new benchmarks for sustainability, inspiring our peers and partners to join us in this transformative journey.”
This Collective is one element of PA and PulPac’s mission to leverage Dry Molded Fiber to convert renewable plant fibers into a wide range of sustainable packaging and products. DMF delivers a better environmental footprint than single-use plastics at comparable speed, scalability, and cost.
As the global brand development partner for DMF technology, PA works closely with renowned brands to develop tailored packaging and product solutions. In our Collective approach, we work with multiple brand partners to address global and industry-wide sustainability challenges, taking collective action to make a positive impact on the world.
Sanofi's Consumer Healthcare is a leading consumer healthcare business with presence in 150 countries and over 11,000 employees. Sanofi CHC's mission is to bring health in the hands of people around the world, to make healthcare as simple as it should be and providing self-care solutions to allow people to better manage their personal well-being. Sanofi CHC leverages the best in science, together with its world-class pharmaceutical quality standards, to deliver consumer-driven, brand-led, innovative medicines and solutions for allergy; pain; digestive wellness; cough & cold; and physical and mental wellness.